iasocholine 1 gbq/ml inj. opl. i.v. multidos. cont.
cardioxane 500 mg, pulver zur herstellung einer infusionslösung
clinigen healthcare b.v. (8181225) - dexrazoxan - pulver zur herstellung einer infusionslösung - teil 1 - pulver zur herstellung einer infusionslösung; dexrazoxan (26073) 500 milligramm
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
arosuva 10 mg filmtabletten
gebro pharma gmbh - rosuvastatin calcium -
arosuva 20 mg filmtabletten
gebro pharma gmbh - rosuvastatin calcium -
arosuva 40 mg filmtabletten
gebro pharma gmbh - rosuvastatin calcium -
arosuva 5 mg filmtabletten
gebro pharma gmbh - rosuvastatin calcium -
tadalafil genericon 10 mg filmtabletten
genericon pharma gmbh - tadalafil -
tadalafil genericon 20 mg filmtabletten
genericon pharma gmbh - tadalafil -
tadalafil genericon 5 mg filmtabletten
genericon pharma gmbh - tadalafil -